Global Cyclosporine Sales Market Report 2024
Market Analysis and InsightsGlobal Cyclosporine Market
Cyclosporine is an immunosuppressant medicine and natural product administered via injection and mouth into veins for the treatment of rheumatoid psoriasis, arthritis, nephrotic syndrome, Crohn's disease, and in organ transplants to prevent rejection.
Due to the COVID-19 pandemic, the global Cyclosporine market size is estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Pills accounting for % of the Cyclosporine global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
In addition, it is used as eye drops for dry eyes. Ciclosporin was extracted from the fungus Tolypocladium inflatum, and was eventually used for medicinal purposes.
Global Cyclosporine Scope and Market Size
The global Cyclosporine market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Cyclosporine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Pills
Oral
Segment by Application
Hospital
Clinic
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Alcon
Allergan
Herantis Pharma
Mimetogen Pharmaceuticals
Mitotech
Otsuka Pharmaceutical
Regenerx Biopharmaceuticals
Santen Pharmaceutical
Takeda
United Biotech
Table of Content
1 Cyclosporine Market Overview
1.1 Cyclosporine Product Scope
1.2 Cyclosporine Segment by Type
1.2.1 Global Cyclosporine Sales by Type (2018 & 2024 & 2034)
1.2.2 Pills
1.2.3 Oral
1.3 Cyclosporine Segment by Application
1.3.1 Global Cyclosporine Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Cyclosporine Market Estimates and Forecasts (2018-2034)
1.4.1 Global Cyclosporine Market Size in Value Growth Rate (2018-2034)
1.4.2 Global Cyclosporine Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global Cyclosporine Price Trends (2018-2034)
2 Cyclosporine Estimates and Forecasts by Region
2.1 Global Cyclosporine Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global Cyclosporine Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Cyclosporine Sales Market Share by Region (2018-2023)
2.2.2 Global Cyclosporine Revenue Market Share by Region (2018-2023)
2.3 Global Cyclosporine Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global Cyclosporine Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global Cyclosporine Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cyclosporine Estimates and Projections (2018-2034)
2.4.2 Europe Cyclosporine Estimates and Projections (2018-2034)
2.4.3 China Cyclosporine Estimates and Projections (2018-2034)
2.4.4 Japan Cyclosporine Estimates and Projections (2018-2034)
2.4.5 Southeast Asia Cyclosporine Estimates and Projections (2018-2034)
2.4.6 India Cyclosporine Estimates and Projections (2018-2034)
3 Global Cyclosporine Competition Landscape by Players
3.1 Global Top Cyclosporine Players by Sales (2018-2023)
3.2 Global Top Cyclosporine Players by Revenue (2018-2023)
3.3 Global Cyclosporine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cyclosporine as of 2024)
3.4 Global Cyclosporine Average Price by Company (2018-2023)
3.5 Manufacturers Cyclosporine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Cyclosporine Market Size by Type
4.1 Global Cyclosporine Historic Market Review by Type (2018-2023)
4.1.1 Global Cyclosporine Sales by Type (2018-2023)
4.1.2 Global Cyclosporine Revenue by Type (2018-2023)
4.1.3 Global Cyclosporine Price by Type (2018-2023)
4.2 Global Cyclosporine Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global Cyclosporine Sales Forecast by Type (2024-2034)
4.2.2 Global Cyclosporine Revenue Forecast by Type (2024-2034)
4.2.3 Global Cyclosporine Price Forecast by Type (2024-2034)
5 Global Cyclosporine Market Size by Application
5.1 Global Cyclosporine Historic Market Review by Application (2018-2023)
5.1.1 Global Cyclosporine Sales by Application (2018-2023)
5.1.2 Global Cyclosporine Revenue by Application (2018-2023)
5.1.3 Global Cyclosporine Price by Application (2018-2023)
5.2 Global Cyclosporine Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global Cyclosporine Sales Forecast by Application (2024-2034)
5.2.2 Global Cyclosporine Revenue Forecast by Application (2024-2034)
5.2.3 Global Cyclosporine Price Forecast by Application (2024-2034)
6 United States Cyclosporine Market Facts & Figures
6.1 United States Cyclosporine Sales by Company
6.1.1 United States Cyclosporine Sales by Company (2018-2023)
6.1.2 United States Cyclosporine Revenue by Company (2018-2023)
6.2 United States Cyclosporine Sales Breakdown by Type
6.2.1 United States Cyclosporine Sales Breakdown by Type (2018-2023)
6.2.2 United States Cyclosporine Sales Breakdown by Type (2024-2034)
6.3 United States Cyclosporine Sales Breakdown by Application
6.3.1 United States Cyclosporine Sales Breakdown by Application (2018-2023)
6.3.2 United States Cyclosporine Sales Breakdown by Application (2024-2034)
7 Europe Cyclosporine Market Facts & Figures
7.1 Europe Cyclosporine Sales by Company
7.1.1 Europe Cyclosporine Sales by Company (2018-2023)
7.1.2 Europe Cyclosporine Revenue by Company (2018-2023)
7.2 Europe Cyclosporine Sales Breakdown by Type
7.2.1 Europe Cyclosporine Sales Breakdown by Type (2018-2023)
7.2.2 Europe Cyclosporine Sales Breakdown by Type (2024-2034)
7.3 Europe Cyclosporine Sales Breakdown by Application
7.3.1 Europe Cyclosporine Sales Breakdown by Application (2018-2023)
7.3.2 Europe Cyclosporine Sales Breakdown by Application (2024-2034)
8 China Cyclosporine Market Facts & Figures
8.1 China Cyclosporine Sales by Company
8.1.1 China Cyclosporine Sales by Company (2018-2023)
8.1.2 China Cyclosporine Revenue by Company (2018-2023)
8.2 China Cyclosporine Sales Breakdown by Type
8.2.1 China Cyclosporine Sales Breakdown by Type (2018-2023)
8.2.2 China Cyclosporine Sales Breakdown by Type (2024-2034)
8.3 China Cyclosporine Sales Breakdown by Application
8.3.1 China Cyclosporine Sales Breakdown by Application (2018-2023)
8.3.2 China Cyclosporine Sales Breakdown by Application (2024-2034)
9 Japan Cyclosporine Market Facts & Figures
9.1 Japan Cyclosporine Sales by Company
9.1.1 Japan Cyclosporine Sales by Company (2018-2023)
9.1.2 Japan Cyclosporine Revenue by Company (2018-2023)
9.2 Japan Cyclosporine Sales Breakdown by Type
9.2.1 Japan Cyclosporine Sales Breakdown by Type (2018-2023)
9.2.2 Japan Cyclosporine Sales Breakdown by Type (2024-2034)
9.3 Japan Cyclosporine Sales Breakdown by Application
9.3.1 Japan Cyclosporine Sales Breakdown by Application (2018-2023)
9.3.2 Japan Cyclosporine Sales Breakdown by Application (2024-2034)
10 Southeast Asia Cyclosporine Market Facts & Figures
10.1 Southeast Asia Cyclosporine Sales by Company
10.1.1 Southeast Asia Cyclosporine Sales by Company (2018-2023)
10.1.2 Southeast Asia Cyclosporine Revenue by Company (2018-2023)
10.2 Southeast Asia Cyclosporine Sales Breakdown by Type
10.2.1 Southeast Asia Cyclosporine Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Cyclosporine Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia Cyclosporine Sales Breakdown by Application
10.3.1 Southeast Asia Cyclosporine Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Cyclosporine Sales Breakdown by Application (2024-2034)
11 India Cyclosporine Market Facts & Figures
11.1 India Cyclosporine Sales by Company
11.1.1 India Cyclosporine Sales by Company (2018-2023)
11.1.2 India Cyclosporine Revenue by Company (2018-2023)
11.2 India Cyclosporine Sales Breakdown by Type
11.2.1 India Cyclosporine Sales Breakdown by Type (2018-2023)
11.2.2 India Cyclosporine Sales Breakdown by Type (2024-2034)
11.3 India Cyclosporine Sales Breakdown by Application
11.3.1 India Cyclosporine Sales Breakdown by Application (2018-2023)
11.3.2 India Cyclosporine Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in Cyclosporine Business
12.1 Alcon
12.1.1 Alcon Corporation Information
12.1.2 Alcon Business Overview
12.1.3 Alcon Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Alcon Cyclosporine Products Offered
12.1.5 Alcon Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Allergan Cyclosporine Products Offered
12.2.5 Allergan Recent Development
12.3 Herantis Pharma
12.3.1 Herantis Pharma Corporation Information
12.3.2 Herantis Pharma Business Overview
12.3.3 Herantis Pharma Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Herantis Pharma Cyclosporine Products Offered
12.3.5 Herantis Pharma Recent Development
12.4 Mimetogen Pharmaceuticals
12.4.1 Mimetogen Pharmaceuticals Corporation Information
12.4.2 Mimetogen Pharmaceuticals Business Overview
12.4.3 Mimetogen Pharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Mimetogen Pharmaceuticals Cyclosporine Products Offered
12.4.5 Mimetogen Pharmaceuticals Recent Development
12.5 Mitotech
12.5.1 Mitotech Corporation Information
12.5.2 Mitotech Business Overview
12.5.3 Mitotech Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Mitotech Cyclosporine Products Offered
12.5.5 Mitotech Recent Development
12.6 Otsuka Pharmaceutical
12.6.1 Otsuka Pharmaceutical Corporation Information
12.6.2 Otsuka Pharmaceutical Business Overview
12.6.3 Otsuka Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Otsuka Pharmaceutical Cyclosporine Products Offered
12.6.5 Otsuka Pharmaceutical Recent Development
12.7 Regenerx Biopharmaceuticals
12.7.1 Regenerx Biopharmaceuticals Corporation Information
12.7.2 Regenerx Biopharmaceuticals Business Overview
12.7.3 Regenerx Biopharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Regenerx Biopharmaceuticals Cyclosporine Products Offered
12.7.5 Regenerx Biopharmaceuticals Recent Development
12.8 Santen Pharmaceutical
12.8.1 Santen Pharmaceutical Corporation Information
12.8.2 Santen Pharmaceutical Business Overview
12.8.3 Santen Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Santen Pharmaceutical Cyclosporine Products Offered
12.8.5 Santen Pharmaceutical Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Business Overview
12.9.3 Takeda Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Takeda Cyclosporine Products Offered
12.9.5 Takeda Recent Development
12.10 United Biotech
12.10.1 United Biotech Corporation Information
12.10.2 United Biotech Business Overview
12.10.3 United Biotech Cyclosporine Sales, Revenue and Gross Margin (2018-2023)
12.10.4 United Biotech Cyclosporine Products Offered
12.10.5 United Biotech Recent Development
13 Cyclosporine Manufacturing Cost Analysis
13.1 Cyclosporine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cyclosporine
13.4 Cyclosporine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cyclosporine Distributors List
14.3 Cyclosporine Customers
15 Market Dynamics
15.1 Cyclosporine Industry Trends
15.2 Cyclosporine Market Drivers
15.3 Cyclosporine Market Challenges
15.4 Cyclosporine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer